Bigul

Board Meeting-Outcome of Board Meeting

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose a text of Audited Financial Results of the Company for the fourth quarter and year ended on March 31, 2018, approved by the Board of Directors at its Meeting held on Monday, May 14, 2018, along with the Auditors Report issued by S R B C & CO. LLP, Statutory Auditors of the Company and Declaration...
14-05-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed the copies of Public Notice published as per Regulation 47 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in Business Standard (All Edition) and Loksatta on Friday, May 4, 2018, in connection with the Meeting of the Board of Directors to be held on Monday, May 14, 2018.
04-05-2018
Bigul

Corporate Action-Board to consider Dividend

In terms of Regulation 29 (1) (a) and (e) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 14, 2018 interalia, for the following: 1.To consider and approve the text of Audited Financial Results of the Company for the fourth quarter and year ended on March 31,...
04-05-2018
Bigul

Board Meeting On May 14, 2018

In terms of Regulation 29 (1) (a) and (e) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, May 14, 2018 interalia, for the following: 1.To consider and approve the text of Audited Financial Results of the Company for the fourth quarter and year ended on March 31,...
04-05-2018
Bigul

Announcement under Regulation 30 (LODR)-Change in Directorate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby intimate you that the Board of Directors of the Company have appointed Ms Anisha Motwani (DIN: 06943493) as an Additional and Independent Director of the Company for a term of 3 (three) years effective April 25, 2018, subject to approval of the Shareholders of the Company.
26-04-2018
Bigul

Shareholding for the Period Ended March 31, 2018

Abbott India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click here
17-04-2018
Bigul

Compliance Certificate Under Regulation 40(10) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2018

Please find enclosed Certificate dated April 9, 2018 issued by Ms. Neena Bhatia, Practicing Company Secretary pursuant Regulation 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended March 31, 2018.
09-04-2018
Bigul

Statement Of Investor Complaints For The Quarter Ended March 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0532 Name of the Signatory :- Krupa AnandparaDesignation :- Company Secretary and Compliance Officer
04-04-2018
Bigul

Compliance Certificate For The Year Ended March 31, 2018.

Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Compliance Certificate dated April 4, 2018, duly signed by the Compliance Officer of the Company and Authorized Representative of the Registrar and Share Transfer Agent i.e., Karvy Computershare Private Limited for the year ended March 31, 2018.
04-04-2018
Bigul

Corona Remedies acquires specific brand portfolio from Abbott India

Plan for substantially changing revenue mix over 3 years
02-04-2018
Next Page
Close

Let's Open Free Demat Account